Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details 1)

v3.20.2
STOCKHOLDERS' EQUITY (DEFICIT) (Details 1)
3 Months Ended
Mar. 31, 2020
$ / shares
shares
Equity (Deficit):  
Number of options outstanding, beginning | shares 4,671,280
Number of options granted | shares 1,000,000
Number of options forfeited | shares (861,458)
Number of options outstanding, ending | shares 4,809,822
Number of options exercisable | shares 3,450,448
Weighted average exercise price outstanding, beginning | $ / shares $ .29
Weighted average exercise price granted | $ / shares .30
Weighted average exercise price forfeited | $ / shares .53
Weighted average exercise price outstanding, ending | $ / shares .29
Weighted average exercise price, exercisable | $ / shares $ .25
Weighted average remaining contractual life outstanding, beginning 7 years 3 months 14 days
Weighted average remaining contractual life granted 10 years
Weighted average remaining contractual life forfeited 0 years
Weighted average remaining contractual life outstanding, ending 8 years 11 months 8 days
Weighted average remaining contractual life exercisable 8 years 9 months 7 days